Accumulating evidence for a role of TCF7L2 variants in bipolar disorder with elevated body mass index

Bipolar Disorders

Volumn 18, Issue 2, 2016, Pages 124-135

  Cuellar Barboza, Alfredo B ^a,b   Winham, Stacey J ^a   Mcelroy, Susan L ^c   Geske, Jennifer R ^a   Jenkins, Gregory D ^a   Colby, Colin L ^a   Prieto, Miguel L ^a,d,e   Ryu, Euijung ^a   Cunningham, Julie M ^f   Frye, Mark A ^a   Biernacka, Joanna M ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c LINDNER CENTER OF HOPE   (United States)

^d UNIVERSIDAD DE LOS ANDES   (Venezuela)

^e UNIVERSIDAD DE LOS ANDES   (Chile)

^f MAYO CLINIC ROCHESTER   (United States)

Author keywords

Bipolar disorder; Body mass index; Obesity; TCF7L2

Indexed keywords

TRANSCRIPTION FACTOR 7 LIKE 2; WNT PROTEIN; TCF7L2 PROTEIN, HUMAN;

ADULT; ARTICLE; BIPOLAR DISORDER; BODY MASS; COMORBIDITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS; SINGLE NUCLEOTIDE POLYMORPHISM; TCF7L2 GENE; WNT SIGNALING PATHWAY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MIDDLE AGED;

ADULT; BIPOLAR DISORDER; BODY MASS INDEX; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 84961590512     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12368     Document Type: Article

References (45)

1. Frye MA. Clinical practice. Bipolar disorder-a focus on depression. N Engl J Med 2011; 364: 51-59.
2. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73: 123-231.
3. Osby U, Brandt L, Correia N et al. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry 2001; 58: 844-850.
4. Lichtenstein P, Yip BH, Bjork C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373: 234-239.
5. Craddock N, Sklar P. Genetics of bipolar disorder. Lancet 2013; 381: 1654-1662.
6. Psychiatric GCBDWG. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 2011; 43: 977-983.
7. Cichon S, Muhleisen TW, Degenhardt FA et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet 2011; 88: 372-381.
8. Muhleisen TW, Leber M, Schulze TG et al. Genome-wide association study reveals two new risk loci for bipolar disorder. Nat Commun 2014; 5: 3339.
9. Winham SJ, Cuellar-Barboza AB, Oliveros A et al. Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2. Mol Psychiatry 2014; 19: 1010-1016.
10. Sicras A, Rejas J, Navarro R, Serrat J, Blanca M. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database. Bipolar Disord 2008; 10: 607-616.
11. Goldstein BI, Liu SM, Schaffer A, Sala R, Blanco C. Obesity and the three-year longitudinal course of bipolar disorder. Bipolar Disord 2013; 15: 284-293.
12. McElroy SL, Crow S, Biernacka JM et al. Clinical phenotype of bipolar disorder with comorbid binge eating disorder. J Affect Disord 2013; 150: 981-986.
13. Wosiski-Kuhn M, Erion JR, Gomez-Sanchez EP et al. Glucocorticoid receptor activation impairs hippocampal plasticity by suppressing BDNF expression in obese mice. Psychoneuroendocrinology 2014; 42: 165-177.
14. Segal NL, Allison DB. Twins and virtual twins: bases of relative body weight revisited. Int J Obes Relat Metab Disord 2002; 26: 437-441.
15. Yang J, Loos RJ, Powell JE et al. FTO genotype is associated with phenotypic variability of body mass index. Nature 2012; 490: 267-272.
16. Manning AK, Hivert MF, Scott RA et al. A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet 2012; 44: 659-669.
17. Timpson NJ, Lindgren CM, Weedon MN et al. Adiposity-related heterogeneity in patterns of type 2 diabetes susceptibility observed in genome-wide association data. Diabetes 2009; 58: 505-510.
18. Valvezan AJ, Klein PS. GSK-3 and Wnt signaling in neurogenesis and bipolar disorder. Front Mol Neurosci 2012; 5: 1.
19. Colantuoni C, Lipska BK, Ye T et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex. Nature 2011; 478: 519-523.
20. Olson JE, Ryu E, Johnson KJ et al. The Mayo Clinic Biobank: a building block for individualized medicine. Mayo Clin Proc 2013; 88: 952-962.
21. Schaid DJ, McDonnell SK, Wang L et al. Caution on pedigree haplotype inference with software that assumes linkage equilibrium. Am J Hum Genet 2002; 71: 992-995.
22. Gauderman WJ, Murcray C, Gilliland F et al. Testing association between disease and multiple SNPs in a candidate gene. Genet Epidemiol 2007; 31: 383-395.
23. Team RDC. A language and environment for statistical computing. Vienna, Austria: RDC, 2011.
24. Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005; 102: 15545-15550.
25. Nyholm M, Gullberg B, Merlo J et al. The validity of obesity based on self-reported weight and height: Implications for population studies. Obesity (Silver Spring) 2007; 15: 197-208.
26. Skeie G, Mode N, Henningsen M et al. Validity of self-reported body mass index among middle-aged participants in the Norwegian Women and Cancer study. Clin Epidemiol 2015; 7: 313-323.
27. Thomas D. Gene-environment-wide association studies: emerging approaches. Nat Rev Genet 2010; 11: 259-272.
28. Mechanic LE, Chen HS, Amos CI et al. Next generation analytic tools for large scale genetic epidemiology studies of complex diseases. Genet Epidemiol 2012; 36: 22-35.
29. Grant SF, Thorleifsson G, Reynisdottir I et al. Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006; 38: 320-323.
30. Kim WY, Snider WD. Functions of GSK-3 Signaling in development of the nervous system. Front Mol Neurosci 2011; 4: 44.
31. Oliva CA, Vargas JY, Inestrosa NC. Wnts in adult brain: from synaptic plasticity to cognitive deficiencies. Front Cell Neurosci 2013; 7: 224.
32. Simonson MA, Winham SJ, Jenkins GD et al. Role of the Wnt signaling pathway in bipolar disorder susceptibility: Gene-set analysis of SNP-BMI interaction effects. Presented at the 63rd Annual Meeting of The American Society of Human Genetics October 23, 2013 in Boston, MA.
33. Brennand KJ, Simone A, Jou J et al. Modelling schizophrenia using human induced pluripotent stem cells. Nature 2011; 473: 221-225.
34. Hansen T, Ingason A, Djurovic S et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol Psychiatry 2011; 70: 59-63.
35. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
36. Benedetti F, Bollettini I, Barberi I et al. Lithium and GSK3-beta promoter gene variants influence white matter microstructure in bipolar disorder. Neuropsychopharmacology 2013; 38: 313-327.
37. Pandey GN, Rizavi HS, Tripathi M, Ren X. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia. Bipolar Disord 2015; 17: 160-171.
38. Ray R, Barrett M, Thase M et al. Friday abstracts. Biol Psychiatry 2014; 75: S135-S274.
39. Madison JM, Zhou F, Nigam A et al. Characterization of bipolar disorder patient-specific induced pluripotent stem cells from a family reveals neurodevelopmental and mRNA expression abnormalities. Mol Psychiatry 2015; 20: 703-717.
40. Guo T, Hanson RL, Traurig M et al. TCF7L2 is not a major susceptibility gene for type 2 diabetes in Pima Indians: analysis of 3, 501 individuals. Diabetes 2007; 56: 3082-3088.
41. Benzler J, Andrews ZB, Pracht C et al. Hypothalamic WNT signalling is impaired during obesity and reinstated by leptin treatment in male mice. Endocrinology 2013; 154: 4737-4745.
42. Roswall N, Angquist L, Ahluwalia TS et al. Association between Mediterranean and Nordic diet scores and changes in weight and waist circumference: influence of FTO and TCF7L2 loci. Am J Clin Nutr 2014; 100: 1188-1197.
43. Hill EJ, Nagel DA, O'Neil JD et al. Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS ONE 2013; 8: e58822.
44. Davey Smith G, Hemani G. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 2014; 23: R89-R98.
45. Walter S, Kubzansky LD, Koenen KC et al. Revisiting mendelian randomization studies of the effect of body mass index on depression. Am J Med Genet B Neuropsychiatr Genet 2015; 168: 108-115.